GSK Unit Pauses Chancery Patent Suit For Settlement Talks
A specialty pharma company majority-owned by GlaxoSmithKline has agreed to stay its Delaware Chancery Court lawsuit against a San Francisco biotech startup it accuses of butting into a university research collaboration...To view the full article, register now.
Already a subscriber? Click here to view full article